Sponsor of the Day:
Jerkmate
https://reports.statnews.com/collections/all-reports/products/treating-depression-report
Treating Depression: A new era of promising drugs | STAT Reports
STAT’s latest report details the challenges, possibilities and frontrunners in the race to remake treatment of the world’s most common mental health problem.
treating depressionnew eradrugs statpromisingreports
https://www.statnews.com/2025/10/06/telehealth-companies-shift-from-providing-patient-access-to-selling-drugs/
Telehealth companies shifting from access to care to selling drugs | STAT
Mar 12, 2026 - Telehealth began as a way to help patients access doctors, but has rapidly transformed into a way to help companies sell drugs. A STAT special report by Katie...
telehealth companiesselling drugsshiftingaccesscare
https://www.statnews.com/2019/04/29/y-combinator-startups-small-molecule-drugs/
Y Combinator to fund more startups pursuing small-molecule drugs | STAT
Jul 25, 2023 - In a Silicon Valley twist, the compounds Y Combinator is backing will often be recommended by an algorithm designed to identify promising drug candidates.
small moleculedrugs statcombinatorfundstartups
https://www.statnews.com/2025/11/06/trumprx-weight-loss-drug-discounts-wegovy-zepbound/
TrumpRx to offer discount weight loss drugs after Lilly, Novo deals | STAT
Nov 6, 2025 - Novo Nordisk's Wegovy, Eli Lilly's Zepbound to be sold at discounted prices on TrumpRx, covered by Medicare under new Trump deal.
weight loss drugsoffer discountlilly novotrumprxdeals
https://www.statnews.com/2025/06/23/glp-1-drug-helped-type-1-diabetes-patients-keep-healthy-glucose-levels-and-lose-weight/
GLP-1 drugs effective for type 1 diabetes in new study| STAT
Jun 24, 2025 - Now used for type 2 diabetes, new study shows GLP-1 drugs helped people with type 1 keep blood glucose levels in a healthy range while also losing weight.
glp 1 drugstype diabetesnew studyeffectivestat
https://www.statnews.com/2024/05/23/weight-loss-drugs-rna-interference-gene-silencing-regeneron/
For longer-lasting obesity drugs, biotechs turn to gene silencing | STAT
May 24, 2024 - As shown in STAT’s Obesity Drug Tracker, Regeneron and others are using RNA interference to target genetics, rather than hormones like GLP-1.
longer lastingobesity drugsgene silencingbiotechsturn
https://reports.statnews.com/collections/all-reports/products/the-obesity-revolution-how-glp-1-drugs-are-changing-society
The Obesity Revolution: How GLP-1 drugs are changing science, business | STAT Reports
STAT's latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society....
glp 1 drugschanging sciencestat reportsobesityrevolution
https://www.statnews.com/topic/drug-prices/
STAT Drug Prices - The Cost Issues of Prescription Drugs
News and analysis on drug prices. Read about the rising cost of prescription drugs, the impact on the healthcare system and efforts to lower costs.
stat drugprescription drugspricescostissues
https://www.statnews.com/2025/06/17/weight-loss-drugs-glp-1s-agency-health-reframing-motivation/
Weight-loss drugs offer patients the power to change | STAT
Health isn’t just the sum of your metrics. It’s also the experience of living with purpose and possibility.
weight loss drugsofferpatientspowerchange
https://www.statnews.com/2025/06/05/glp-1-drugs-low-but-elevated-risk-of-age-related-macular-degeneration/
GLP-1 drugs may be linked to higher risk of eye disease: study | STAT
Jun 6, 2025 - A study of people with diabetes found the risk of macular degeneration remained low, but was 0.2% in people taking GLP-1s, 0.1% in those who didn't.
glp 1 drugshigher riskeye diseasestudy statmay
https://www.statnews.com/topic/obesity/page/2/
STAT Obesity - New Weight Loss Drugs Change Diet Landscape
Groundbreaking news and analysis about obesity and a new generation of weight-loss drugs, including Ozempic, Wegovy and Mounjaro.
new weight lossstatobesitydrugschange
https://www.statnews.com/2026/02/06/white-house-wants-more-pharma-companies-on-trumprx/
White House wants to add more drugs to TrumpRx | STAT
Feb 6, 2026 - The Trump administration is working to get more companies to offer prescription drugs at discounted cash prices on TrumpRx.
white house wantstrumprx statadddrugs
https://www.statnews.com/2026/01/28/how-gas-station-drugs-remain-legal/
'Gas station drugs' are everywhere. How long will they remain legal? | STAT
This week’s STATus Report digs into how and why gas stations became the perfect marketplace for quasi-legal
gas stationdrugseverywherelongremain
https://www.statnews.com/2026/03/19/antipsychotic-drug-misuse-nursing-homes-hhs-oig-reports/
HHS watchdog details misuse of antipsychotic drugs in nursing homes | STAT
Federal watchdog says nursing homes use antipsychotic drugs as 'chemical restraints' on dementia patients, disguise practice as schizophrenia treatment.
antipsychotic drugsnursing homeshhswatchdogdetails
https://www.statnews.com/topic/obesity/
STAT Obesity - New Weight Loss Drugs Change Diet Landscape
Groundbreaking news and analysis about obesity and a new generation of weight-loss drugs, including Ozempic, Wegovy and Mounjaro.
new weight lossstatobesitydrugschange
https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/
Weight loss drugs on the horizon: STAT's Obesity Drug Tracker
Jun 17, 2025 - Our database tracks the new weight loss drugs that could hit the market, novel mechanisms, and which companies are in the hunt.
weight loss drugshorizonstatobesitytracker
https://www.statnews.com/topic/psychedelics/
Psychedelic Drugs: Coverage of the Latest Medical News - STAT
Stay up to date on the latest news and research on using psychedelic drugs to treat mental illness, including depression, anxiety and PTSD.
latest medical newspsychedelic drugscoveragestat
https://www.statnews.com/2026/04/21/tortugas-neuroscience-jiangsu-hansoh-eisai/
Tortugas Neuroscience will develop drugs for brain disorders | STAT
The biotech startup, financed with $106 million from Cure Ventures and other firms, has licensed therapies from China’s Jiangsu Hansoh and Japan’s Eisai.
brain disorderstortugasneurosciencedevelopdrugs
https://reports.statnews.com/collections/all-reports/products/the-obesity-revolution-how-glp-1-drugs-are-changing-society?variant=40497160257639
The Obesity Revolution: How GLP-1 drugs are changing science, business | STAT Reports
STAT's latest report dives into new GLP-1-based obesity drugs like Ozempic and Wegovy and explores their impact on science, business, health care, and society....
glp 1 drugschanging sciencestat reportsobesityrevolution
https://www.statnews.com/2024/09/05/obesity-drug-tracker-amylin-weight-loss-drugs-novo-nordisk-eli-lilly-zealand-pharma/
Obesity drug tracker: Can amylin drugs upend Wegovy, Zepbound? | STAT
Sep 5, 2024 - Novo Nordisk and Eli Lilly, makers of blockbuster GLP-1 drugs, test amylin hormone receptor treatments in pursuit of fewer side effects.
obesity drugwegovy zepboundtrackeramylindrugs
https://www.statnews.com/pharmalot/2026/04/16/alzheimers-drugs-review-fda-panel-for-compounded-peptides/
Pharmalittle: Alzheimer's drugs reviewed, FDA panel to vet peptides | STAT
Apr 16, 2026 - A new report released by Senate Democrats finds that prescription drug prices have continued to climb — in some cases, sharply.
pharmalittlealzheimerdrugsreviewedfda